Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
KPTI
Stock Latest News
Company Announcements
Karyopharm Faces Liquidity Crisis Under Forbearance Agreement
6d ago
8K
KPTI
Premium
The Fly
Karyopharm, guarantors enter into forbearance agreement
6d ago
KPTI
Premium
Company Announcements
Karyopharm Seeks Accelerated FDA Approval for XPOVIO Combo
17d ago
8K
KPTI
Premium
The Fly
Karyopharm submits sNDA to FDA for XPOVIO
17d ago
KPTI
Premium
Company Announcements
Karyopharm (KPTI) Earnings Call: Promise vs. Pressure
22d ago
KPTI
Premium
The Fly
Largest borrow rate increases among liquid names
30d ago
YSS
ABCL
Premium
The Fly
Karyopharm reports Q2 EPS ($2.32) vs. ($4.32) last year
1M ago
KPTI
Premium
The Fly
Karyopharm sees FY26 revenue $130M-$150M, consensus $133.74M
1M ago
KPTI
Premium
The Fly
Karyopharm evaluating financing opportunities and strategic alternatives
1M ago
KPTI
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
CRML
IMSR
Premium
Pre-Earnings
KPTI Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
KPTI
Premium
The Fly
Largest borrow rate increases among liquid names
1M ago
XE
VCX
Premium
Weekend Updates
GoDaddy, NXT, Karyopharm, AXT, Enbridge Trending With Analysts
2M ago
ENB
NXT
Premium
The Fly
Karyopharm price target lowered to $11 from $14 at Jefferies
2M ago
KPTI
Premium
Company Announcements
Karyopharm Reports Selinexor Trial Results, Explores Strategic Options
2M ago
8K
KPTI
Premium
The Fly
Karyopharm price target lowered to $7 from $16 at Piper Sandler
2M ago
KPTI
Premium
The Fly
Karyopharm downgraded to Neutral from Buy at H.C. Wainwright
2M ago
KPTI
Premium
The Fly
Karyopharm downgraded to Neutral from Outperform at Baird
2M ago
KPTI
Premium
The Fly
Karyopharm down 69% after XPORT-EC-042 trial did not meet primary endpoint
2M ago
KPTI
Premium
The Fly
Karyopharm to submit sNDA for selinexor plus ruxolitinib
2M ago
KPTI
Premium
The Fly
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint
2M ago
KPTI
Premium
The Fly
Karyopharm trading resumes
2M ago
KPTI
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
